More NewsRead More
TetraLogic Announces Initiation of a Randomized Phase 2 Clinical Trial of SHAPE in Subjects With Cutaneous T-Cell Lymphoma
December 18, 2014
TetraLogic Provides Update on Ovarian Cancer Study
December 16, 2014
TetraLogic Pharmaceuticals Announces Clinical Data on Birinapant to be Presented at the 56th Annual American Society of Hematology Annual Meeting
December 04, 2014
TetraLogic to Participate in Two Conferences in December
December 02, 2014
TetraLogic Pharmaceuticals Announces Results of Preclinical Studies in Hepatitis B
November 10, 2014
TetraLogic Pharmaceuticals Announces Appointment of Mary Ann Gray, Ph.D. and Mr. Michael D. Kishbauch as New Directors
November 07, 2014
TetraLogic Reports Third Quarter Financial Results and Provides Clinical Programs Update
November 05, 2014
TetraLogic Pharmaceuticals to Host Investor Forum on November 10, 2014
November 03, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here